Docstoc

Scope and Significance of Market Research

Document Sample
Scope and Significance of Market Research Powered By Docstoc
					Brochure
More information from http://www.researchandmarkets.com/reports/359138/




U.S. Asthma Therapeutics Market

Description:

                New Product Classes Offer Significant Growth Opportunities

                The emergence of leukotriene modifiers and combination therapies show
                promise in a highly competitive market. Leukotriene modifiers are

                maintenance therapy drugs and an alternative to the long-term use of
                corticosteroids. Convenience is the primary advantage of combination
                therapies, as these pills combine two or more asthma drugs into one dosage,
                making treatment more efficient. Both product classes result in increased

                compliance as patients realize the benefits of these orally-administered and
                easy-to-use therapies.

                This Frost &Sullivan study forecasts future revenues of the drug classes that
                dominate the prescription asthma drug market: brochodilators, anti-inflammatories, leukotriene
                modifiers, and combined therapies, while also offering an
                overview of new drug classes in development. This deliverable provides
                market drivers and restraints for each drug segment, and recommends
                strategies to formulate an efficient business plan.

                Developing Brand Loyalty Essential for Success

                It is important that drug manufacturers market their asthma therapies to all

                healthcare groups that diagnose and treat asthma in an effort to build brand
                loyalty. Asthma is treated by a number of different medical professionals,
                including primary care physicians, respiratory specialists, and emergency room
                doctors, all of whom use diverse treatments for this disease.

                The primary care physician segment presents the largest opportunity to build
                a successful and loyal following. Primary care providers account for nearly 56
                percent of all prescriptions written for asthma medications, states the author
                of this study. Implementing educational campaigns to promote brand loyalty
                among all provider groups is a key opportunity to increase market share.

                Market for Mild Asthmatics Poised for Expansion

                An estimated 90 percent of patients suffering from severe persistent asthma
                get treated with prescription drugs, while only five to eight percent of mild
                intermittent cases receive prescriptions, states the author..
                The mild intermittent patient group has a huge revenue potential, as it
                represents the largest patient segment. Companies that can increase their
                penetration rates among this group through new, innovative therapies, and
                targeted marketing campaigns, see greater returns on their investments.

                This Frost &Sullivan research provides the most current intelligence available
                on the U.S. asthma therapeutics market. By identifying the latest drivers and
                restraints this report enables you to fully evaluate this market 's potential and
                design strategies for future success.

                Additional Information

                Market Participants
                Alpharma,Inc./U.S.Pharmaceutical Division
            AstraZeneca

            AstraZeneca LP
            Aventis Pharmaceuticals,Inc.
            Bausch &Lomb Pharmaceuticals,Inc.

            Boehringer Ingelheim
            Copley Pharmaceuticals,Inc.
            Dey,Inc.
            Dura Pharmaceuticals,Inc.

            GlaxoSmithKline

            Medeva Pharmaceuticals

            Novartis Pharmaceuticals Corporation

            Pfizer

            Purdue Pharma LP
            Sanofi-Synthelabo,Inc.

            Schering-Plough HealthCare Products

            Teva Pharmaceutials USA

            Related Companies

            3M Pharmaceuticals

            Alliance Pharmaceuticals Corporation
            Berlex Laboratories,Inc.

            Inhale Therapeutic Systems

            McKesson HBOC
            Merck-Medco Managed Care,LLC

            Associations

            American Association for Respiratory Care

            American Lung Association

            California Society for Respiratory Care
            National Heart,Lung,and Blood Institute

            National Jewish Medical Research Center

            Trade Organizations

            National Pharmaceutical Council




Contents:   1. Executive Summary
            A. Introduction to the Prescription Asthma Drugs Market
            1.Objectives and Purpose
            2.Report Scope and Segmentation
            3.Report Structure
            B. Summary of Major Findings
            1.Total Revenue Forecasts
2.Percent of Revenues by Product Type
3.Analysis by Major Segment
a. Bronchodilator Asthma Drugs Market
i. Major Drivers for the Bronchodilator Asthma Drugs Market
ii. Major Restraints for the Bronchodilator Asthma Drugs Market
b. Inhaled Anti-Inflammatory Asthma Drugs Market
i. Major Drivers for the Inhaled Anti-Inflammatory Asthma Drugs Market
ii. Major Restraints for the Inhaled Anti-Inflammatory Asthma Drugs Market
c. Leukotriene Modifiers and Emerging Asthma Drugs Market
i. Major Drivers for the Leukotriene Modifiers Asthma Drugs Market
ii. Major Restraints for the Leukotriene Modifiers Asthma Drugs Market
4.Competitive Analysis
a. Competitive Structure
b. Major Players
c. Market Entrants

2.Market Engineering Research Methodology
A. Research Scope
1.Objectives and Purpose
2.Report Structure and Market Segmentation
B. Research Methodology
1.Frost &Sullivan's 12 Step Methodology
2.Step 1:Define Market Problems, Needs, and Opportunities
a. Phase One:Analysis
b. Phase Two: Kickoff Meeting
3.Step 2:Define Objectives and Goals of the Research Project
4.Step 3:Design Optimal Research Team
a. Lead Research Analyst
b. Support Research Analyst
c. Research Directors
d. Account Executives
e. Market Engineering Consultants
f. Key Customers
g. Industry Advisers
5.Step 4:Launch Data Collection Phase
6.Step 5:Select Interview Strategy and

Design of Survey
7.Step 6:Test the Survey Design
8.Step 7:Conduct Primary Market Research
a. Cross-Verification of Data
b. Bottom-Up Approach
c. Bottom-Up Versus Top-Down Approach
d. Measuring Revenue Growth Rate
9.Step 8:Research Analysis: Finding Point A
10.Step 9:Market Forecasting: Finding Point B
a. Expert-Opinion Consensus Model
11.Step 10:Develop Strategic Recommendations
a. Who Is Winning, Who Is Losing, and Why?
12.Step 11:Confirm Results with Quality Control
a. Research Director's Final Review
b. Final Client Preparation
13.Step 12:Market Monitoring and Customer Feedback Review
a. Market Monitoring
b. Customer Feedback and Review
c. Continuous Market Research Monitoring
C. Market Engineering Forecasting Methodology
1.Overview
a .Market Engineering Research Process Completed
b. Measurements and Challenges Analyzed Over Time
c. Identification of Market Drivers and Restraints
d. Expert-Opinion Integration with Analyst Team
E .Forecasts Calculated
f. Delphi Technique Integration When Needed
G .Quality Control Within Research Department
2.Strategic Significance of the Market Engineering Forecast
3.Judging Credibility and Accuracy of Market Engineering Forecasts
4.Forecast Assumptions

3.Identification of Challenges Facing the Pharmaceutical Industry

4.Overview of Asthma
A. Definition
B. Etiology and Pathophysiology of Asthma
1.Disease Overview
2.Inflammation in Asthma
3.Asthma Types
4.Disease Incidence and Patient Population

5.Market Engineering Research for the U.S. Bronchodilator Asthma Drugs Market 1996 -2006
A. Market Overview and Definitions
1.Overview
2.Definition
3.Scope/Segmentation
4.History
5.Applications/Use
B. Market Engineering Research Measurement System
C. Market Drivers
D. Market Restraints
E. Market Engineering Revenue Forecasts (1996 -2006)
1.Patient Population (Demand Analysis)
a. Methodology
b. Major Trends
2.Pricing Analysis
a. Methodology
b. Major Pricing Trends
3.Revenues
F. Technology Trends
G. Competitive Analysis
1.Competitive Structure
2.Competitive Factors
3.Mergers,Alliances, and Acquisitions
4.Market Share Analysis
a. Schering-Plough
b. Glaxo Wellcome
c. Boehringer Ingelheim
H. Product Analysis
1.Products on the Market
a. Proventil and Ventolin (Albuterol)
b. Serevent (Salmeterol)
c. Atrovent (Ipratropium Bromide)
d. Other Drugs
2.Products in Clinical Trials

6.Market Engineering Research for the U.S. Inhaled Anti-Inflammatory Asthma Drugs Market 1996
-2006
A. Market Overview and Definitions
1.Overview
2.Definition
a. Corticosteroids
b. Mast-Cell Stabilizers
3.Scope/Segmentation
4.History
5.Applications/Use
B. Market Engineering Research Measurement System
C. Market Drivers
D. Market Restraints
E. Market Engineering Revenue Forecasts (1996 -2006)
1.Patient Population (Demand Analysis)
a. Methodology
b. Major Trends
2.Pricing Analysis
a. Methodology
b. Major Pricing Trends
3.Revenues
F. Technology Trends
G. Competitive Analysis
1.Competitive Structure
2.Competitive Factors
3.Market Share Analysis
H. Product Analysis
1.Products on the Market
a. Vanceril and Beclovent (Beclomethasone)
b. Flovent (Fluticasone)
c. Pulmicort (Budesonide)
d. Aerobid (Flunisolide)
e. Azmacort (Triamcinolone)
f. Intal (Cromolyn Sodium)and Tilade (Nedocromil Sodium)
2.Products in Clinical Trials

7.Market Engineering Research for the U.S. Leukotriene Modifiers and Emerging Asthma Therapies
Market

1996 -2006
A. Leukotriene Modifiers Asthma Drugs Market
1.Market Overview and Definitions
a. Overview
b. Definition
c. Scope/Segmentation
d. Possible Applications/Use
2.Market Engineering Research Measurement System
3.Market Drivers
4.Market Restraints
5.Patient Population (Demand Analysis)
a. Methodology
b. Major Trends
6.Pricing Analysis
a. Methodology
b. Major Pricing Trends
7.Revenues
8.Competitive Analysis
a. Competitive Structure
b. Competitive Factors
c. Market Share Analysis
9.Product Analysis
a. Products on the Market
i. Accolate (Zafirlukast)
ii. Zyflo (Zileuton)
iii. Singulair (Montelukast)
b. Leukotriene Modifiers in Clinical Trials
B. Combination Asthma Drug Therapies and Emerging Trends
1.Market Overview and Definitions
a. Overview
b. Definition
c. Scope/Segmentation
2.Market Drivers
3.Market Restraints
4.Market Engineering Revenue Forecasts (2000 -2006)
a .Patient Population (Demand Analysis)
            i. Methodology
            ii. Major Trends
            b. Pricing Analysis
            i. Methodology
            ii. Major Pricing Trends
            c. Revenues
            5.Combination Therapies in Clinical Trials
            6.Other Trends in Asthma Therapy
            a. Personalizing Medications
            b. Asthma Physiolab by Entelos
            c. Other Products in Clinical Trials

            8.Market Engineering Strategy
            A. What Is Market Engineering Strategy?
            1.Measurement-Driven Strategy Generation
            a. Market Engineering Challenges Versus Departmental Responsibility
            b. Market Engineering Measurement Trends Versus Departmental Responsibility
            B. Market Engineering Strategic Recommendations
            1.Corporate Management
            2.Marketing
            3.Research and Development

            9.Market Engineering Planning
            A. Integrating Market Engineering into the Business Planning Process
            1.Current Company Status Location
            2.Desired Status
            3.Developing the Strategy
            4.Implementing the Strategy

            10.Implementation of Market Engineering
            A. How to Implement Market Engineering in a Company

            11.Market Engineering Monitoring of the Asthma Drugs Market
            A. Purpose of Market Engineering Monitoring

            12.Market Engineering Awards for the Prescription Asthma Drugs Market
            A. Frost &Sullivan's 2001 Market Engineering Awards
            B. Market Engineering Awards
            1.Award Category: Marketing Strategy Leadership
            a. Award Description
            b. Research Methodology
            c. Measurement Criteria
            d. Award Recipient
            2.Award Category: Product Innovation
            a. Award Description
            b. Research Methodology
            c. Measurement Criteria
            d. Award Recipient
            3.Award Category: Product Line Strategy
            a. Award Description
            b. Research Methodology
            c. Measurement Criteria
            d. Award Recipient




Ordering:   Order Online - http://www.researchandmarkets.com/reports/359138/

            Order by Fax - using the form below

            Order by Post - print the order form below and sent to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
                                                           Page 1 of 2

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-
1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit

http://www.researchandmarkets.com/contact/

Order Information
Please verify that the product information is correct and select the format(s) you require.


               Product Name:           U.S. Asthma Therapeutics Market
               Web Address:            http://www.researchandmarkets.com/reports/359138/
               Office Code:            OC8HPOSRUUORS

Product Formats
Please select the product formats and quantity you require:


                                   Quantity
               Electronic - Site
                                         EURO €3,295.00
               License:
               Electronic -
                                         EURO €4,338.00
               Enterprisewide:
               Electronic and
               Hard Copy -               EURO €4,686.00 + Euro €50 Shipping/Handling *
               Enterprisewide:
               Electronic and
               Hard Copy -               EURO €3,643.00 + Euro €50 Shipping/Handling *
               Site License:


* Shipping/Handling is only charged once per order.



Contact Information
Please enter all the information below in BLOCK CAPITALS


      Title:                  Mr              Mrs           Dr           Miss                 Ms     Prof

      First Name:                                                  Last Name:

      Email Address: *

      Job Title:

      Organisation:

      Address:

      City:

      Postal / Zip Code:

      Country:

      Phone Number:

      Fax Number:

     * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Page 1 of 2
                                                              Page 2 of 2

Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.

          Pay by credit card:                     American Express

                                                  Diners Club

                                                  Master Card

                                                  Visa
                                           Cardholder's Name

                                           Cardholder's Signature

                                           Expiry Date

                                           Card Number

                                           CVV Number

                                           Issue Date
                                           (for Diners Club only)




          Pay by check:                    Please post the check, accompanied by this form, to:

                                           Research and Markets,
                                           Guinness Center,
                                           Taylors Lane,
                                           Dublin 8,
                                           Ireland.


                                           Please transfer funds to:
          Pay by wire transfer:
                                           Account number                   833 130 83
                                           Sort code                        98-53-30
                                           Swift code                       ULSBIE2D
                                           IBAN number                      IE78ULSB98533083313083
                                           Bank Address                 Ulster Bank,
                                                                        27-35 Main Street,
                                                                        Blackrock,
                                                                        Co. Dublin,
                                                                        Ireland.


     If you have a Marketing Code please enter it below:


           Marketing Code:


      Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at
     http://www.researchandmarkets.com/info/terms.asp



                                              Please fax this form to:
                                  (646) 607-1907 or (646) 964-6609 - From USA
                          +353 1 481 1716 or +353 1 653 1571 - From Rest of World

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:26
posted:8/11/2011
language:English
pages:10
Description: Scope and Significance of Market Research document sample